Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.7772 |
Intermediate Similarity |
NPD4515 |
Suspended |
0.755 |
Intermediate Similarity |
NPD7559 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1670 |
Discontinued |
0.7473 |
Intermediate Similarity |
NPD5603 |
Clinical (unspecified phase) |
0.7354 |
Intermediate Similarity |
NPD6608 |
Clinical (unspecified phase) |
0.734 |
Intermediate Similarity |
NPD5025 |
Approved |
0.7314 |
Intermediate Similarity |
NPD824 |
Approved |
0.731 |
Intermediate Similarity |
NPD3802 |
Phase 3 |
0.7305 |
Intermediate Similarity |
NPD743 |
Approved |
0.7293 |
Intermediate Similarity |
NPD2680 |
Approved |
0.7293 |
Intermediate Similarity |
NPD2681 |
Approved |
0.7228 |
Intermediate Similarity |
NPD4493 |
Discontinued |
0.7178 |
Intermediate Similarity |
NPD3893 |
Discontinued |
0.717 |
Intermediate Similarity |
NPD6199 |
Discontinued |
0.7158 |
Intermediate Similarity |
NPD5183 |
Approved |
0.7158 |
Intermediate Similarity |
NPD5186 |
Approved |
0.7108 |
Intermediate Similarity |
NPD4492 |
Approved |
0.7108 |
Intermediate Similarity |
NPD3888 |
Discontinued |
0.7108 |
Intermediate Similarity |
NPD4494 |
Approved |
0.7104 |
Intermediate Similarity |
NPD2821 |
Approved |
0.71 |
Intermediate Similarity |
NPD4456 |
Clinical (unspecified phase) |
0.7098 |
Intermediate Similarity |
NPD5525 |
Clinical (unspecified phase) |
0.7094 |
Intermediate Similarity |
NPD5860 |
Discontinued |
0.7092 |
Intermediate Similarity |
NPD5515 |
Phase 2 |
0.7079 |
Intermediate Similarity |
NPD4082 |
Approved |
0.7074 |
Intermediate Similarity |
NPD6654 |
Clinical (unspecified phase) |
0.7073 |
Intermediate Similarity |
NPD4455 |
Discontinued |
0.7037 |
Intermediate Similarity |
NPD5192 |
Clinical (unspecified phase) |
0.703 |
Intermediate Similarity |
NPD4596 |
Phase 1 |
0.7015 |
Intermediate Similarity |
NPD4465 |
Phase 2 |
0.7015 |
Intermediate Similarity |
NPD4467 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD7071 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD3472 |
Approved |
0.6995 |
Remote Similarity |
NPD2906 |
Approved |
0.6995 |
Remote Similarity |
NPD2907 |
Approved |
0.6995 |
Remote Similarity |
NPD4022 |
Approved |
0.6971 |
Remote Similarity |
NPD3940 |
Clinical (unspecified phase) |
0.6961 |
Remote Similarity |
NPD5294 |
Clinical (unspecified phase) |
0.6952 |
Remote Similarity |
NPD5433 |
Clinical (unspecified phase) |
0.6942 |
Remote Similarity |
NPD7225 |
Discontinued |
0.6935 |
Remote Similarity |
NPD6874 |
Approved |
0.6927 |
Remote Similarity |
NPD4997 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD3372 |
Discontinued |
0.6919 |
Remote Similarity |
NPD2247 |
Approved |
0.6919 |
Remote Similarity |
NPD2249 |
Approved |
0.6907 |
Remote Similarity |
NPD2792 |
Approved |
0.6898 |
Remote Similarity |
NPD6894 |
Phase 1 |
0.6891 |
Remote Similarity |
NPD3154 |
Approved |
0.6891 |
Remote Similarity |
NPD3153 |
Approved |
0.6889 |
Remote Similarity |
NPD1337 |
Clinical (unspecified phase) |
0.6881 |
Remote Similarity |
NPD6478 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD7858 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.6872 |
Remote Similarity |
NPD3783 |
Clinical (unspecified phase) |
0.6866 |
Remote Similarity |
NPD3416 |
Discontinued |
0.6853 |
Remote Similarity |
NPD4539 |
Phase 1 |
0.6839 |
Remote Similarity |
NPD3655 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD6795 |
Clinical (unspecified phase) |
0.6831 |
Remote Similarity |
NPD7318 |
Phase 3 |
0.6823 |
Remote Similarity |
NPD7132 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD7710 |
Clinical (unspecified phase) |
0.68 |
Remote Similarity |
NPD5071 |
Phase 2 |
0.6796 |
Remote Similarity |
NPD2592 |
Discontinued |
0.6786 |
Remote Similarity |
NPD5896 |
Clinical (unspecified phase) |
0.6782 |
Remote Similarity |
NPD6321 |
Discontinued |
0.6782 |
Remote Similarity |
NPD7566 |
Clinical (unspecified phase) |
0.6776 |
Remote Similarity |
NPD6060 |
Clinical (unspecified phase) |
0.6769 |
Remote Similarity |
NPD4084 |
Clinical (unspecified phase) |
0.6758 |
Remote Similarity |
NPD2672 |
Discontinued |
0.6758 |
Remote Similarity |
NPD6741 |
Clinical (unspecified phase) |
0.6757 |
Remote Similarity |
NPD6533 |
Clinical (unspecified phase) |
0.6742 |
Remote Similarity |
NPD8157 |
Clinical (unspecified phase) |
0.6731 |
Remote Similarity |
NPD1945 |
Phase 1 |
0.6731 |
Remote Similarity |
NPD6567 |
Clinical (unspecified phase) |
0.6722 |
Remote Similarity |
NPD7131 |
Phase 3 |
0.6721 |
Remote Similarity |
NPD7317 |
Phase 3 |
0.672 |
Remote Similarity |
NPD5078 |
Clinical (unspecified phase) |
0.6719 |
Remote Similarity |
NPD6293 |
Clinical (unspecified phase) |
0.6714 |
Remote Similarity |
NPD3437 |
Discontinued |
0.6714 |
Remote Similarity |
NPD7180 |
Phase 3 |
0.6712 |
Remote Similarity |
NPD7031 |
Phase 1 |
0.6703 |
Remote Similarity |
NPD1743 |
Approved |
0.6703 |
Remote Similarity |
NPD1742 |
Approved |
0.6703 |
Remote Similarity |
NPD3684 |
Discontinued |
0.6703 |
Remote Similarity |
NPD19 |
Approved |
0.6701 |
Remote Similarity |
NPD7546 |
Discontinued |
0.6698 |
Remote Similarity |
NPD4429 |
Discontinued |
0.6698 |
Remote Similarity |
NPD7542 |
Phase 3 |
0.6685 |
Remote Similarity |
NPD160 |
Clinical (unspecified phase) |
0.6685 |
Remote Similarity |
NPD6884 |
Clinical (unspecified phase) |
0.6683 |
Remote Similarity |
NPD5102 |
Clinical (unspecified phase) |
0.6682 |
Remote Similarity |
NPD7560 |
Approved |
0.6667 |
Remote Similarity |
NPD3808 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD4979 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD5871 |
Discontinued |
0.6667 |
Remote Similarity |
NPD7467 |
Discontinued |
0.6667 |
Remote Similarity |
NPD956 |
Clinical (unspecified phase) |
0.6651 |
Remote Similarity |
NPD683 |
Approved |
0.665 |
Remote Similarity |
NPD1898 |
Discontinued |
0.665 |
Remote Similarity |
NPD7291 |
Discontinued |
0.665 |
Remote Similarity |
NPD3507 |
Phase 2 |
0.6636 |
Remote Similarity |
NPD7186 |
Phase 3 |
0.6634 |
Remote Similarity |
NPD7597 |
Clinical (unspecified phase) |
0.6631 |
Remote Similarity |
NPD4796 |
Discontinued |
0.663 |
Remote Similarity |
NPD3812 |
Clinical (unspecified phase) |
0.6622 |
Remote Similarity |
NPD3006 |
Discontinued |
0.6622 |
Remote Similarity |
NPD7853 |
Phase 2 |
0.662 |
Remote Similarity |
NPD3912 |
Discontinued |
0.6615 |
Remote Similarity |
NPD3965 |
Phase 1 |
0.6615 |
Remote Similarity |
NPD3793 |
Phase 3 |
0.6614 |
Remote Similarity |
NPD5847 |
Phase 1 |
0.6604 |
Remote Similarity |
NPD8149 |
Discontinued |
0.6604 |
Remote Similarity |
NPD2433 |
Clinical (unspecified phase) |
0.6601 |
Remote Similarity |
NPD7811 |
Phase 3 |
0.6601 |
Remote Similarity |
NPD7810 |
Phase 3 |
0.6598 |
Remote Similarity |
NPD7149 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD7449 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD5966 |
Clinical (unspecified phase) |
0.6597 |
Remote Similarity |
NPD6720 |
Clinical (unspecified phase) |
0.6593 |
Remote Similarity |
NPD950 |
Clinical (unspecified phase) |
0.6589 |
Remote Similarity |
NPD3258 |
Approved |
0.6589 |
Remote Similarity |
NPD2899 |
Discontinued |
0.6588 |
Remote Similarity |
NPD3945 |
Discontinued |
0.6587 |
Remote Similarity |
NPD1421 |
Approved |
0.6587 |
Remote Similarity |
NPD1420 |
Approved |
0.6577 |
Remote Similarity |
NPD2951 |
Discontinued |
0.6576 |
Remote Similarity |
NPD951 |
Approved |
0.6576 |
Remote Similarity |
NPD4201 |
Clinical (unspecified phase) |
0.6574 |
Remote Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.657 |
Remote Similarity |
NPD7174 |
Clinical (unspecified phase) |
0.6569 |
Remote Similarity |
NPD7255 |
Clinical (unspecified phase) |
0.6562 |
Remote Similarity |
NPD4020 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD3983 |
Phase 3 |
0.6561 |
Remote Similarity |
NPD3984 |
Clinical (unspecified phase) |
0.6561 |
Remote Similarity |
NPD5262 |
Discontinued |
0.6561 |
Remote Similarity |
NPD7126 |
Discontinued |
0.6549 |
Remote Similarity |
NPD6716 |
Phase 1 |
0.6545 |
Remote Similarity |
NPD2248 |
Approved |
0.6545 |
Remote Similarity |
NPD5022 |
Discontinued |
0.6545 |
Remote Similarity |
NPD2246 |
Approved |
0.6544 |
Remote Similarity |
NPD7547 |
Clinical (unspecified phase) |
0.6544 |
Remote Similarity |
NPD7820 |
Phase 3 |
0.6541 |
Remote Similarity |
NPD7011 |
Discontinued |
0.6541 |
Remote Similarity |
NPD1769 |
Discontinued |
0.6538 |
Remote Similarity |
NPD5514 |
Discontinued |
0.6538 |
Remote Similarity |
NPD5143 |
Clinical (unspecified phase) |
0.6538 |
Remote Similarity |
NPD7043 |
Discontinued |
0.6537 |
Remote Similarity |
NPD6238 |
Discontinued |
0.6536 |
Remote Similarity |
NPD6017 |
Discontinued |
0.6531 |
Remote Similarity |
NPD7280 |
Phase 3 |
0.6531 |
Remote Similarity |
NPD4078 |
Clinical (unspecified phase) |
0.6531 |
Remote Similarity |
NPD7281 |
Phase 3 |
0.6528 |
Remote Similarity |
NPD3050 |
Clinical (unspecified phase) |
0.6528 |
Remote Similarity |
NPD7556 |
Discontinued |
0.6524 |
Remote Similarity |
NPD3392 |
Approved |
0.652 |
Remote Similarity |
NPD7565 |
Approved |
0.6519 |
Remote Similarity |
NPD979 |
Approved |
0.6515 |
Remote Similarity |
NPD8103 |
Clinical (unspecified phase) |
0.6514 |
Remote Similarity |
NPD7821 |
Clinical (unspecified phase) |
0.6505 |
Remote Similarity |
NPD2779 |
Approved |
0.6505 |
Remote Similarity |
NPD7316 |
Discontinued |
0.6498 |
Remote Similarity |
NPD4049 |
Phase 2 |
0.6497 |
Remote Similarity |
NPD6021 |
Clinical (unspecified phase) |
0.6492 |
Remote Similarity |
NPD4083 |
Discontinued |
0.6489 |
Remote Similarity |
NPD1309 |
Phase 2 |
0.6489 |
Remote Similarity |
NPD1307 |
Phase 2 |
0.6486 |
Remote Similarity |
NPD2366 |
Approved |
0.6485 |
Remote Similarity |
NPD3473 |
Clinical (unspecified phase) |
0.648 |
Remote Similarity |
NPD5481 |
Discontinued |
0.6479 |
Remote Similarity |
NPD5293 |
Phase 2 |
0.6477 |
Remote Similarity |
NPD6645 |
Clinical (unspecified phase) |
0.6477 |
Remote Similarity |
NPD2822 |
Clinical (unspecified phase) |
0.6471 |
Remote Similarity |
NPD5967 |
Approved |
0.6462 |
Remote Similarity |
NPD6297 |
Approved |
0.6458 |
Remote Similarity |
NPD6607 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD7268 |
Clinical (unspecified phase) |
0.6455 |
Remote Similarity |
NPD3259 |
Approved |
0.645 |
Remote Similarity |
NPD4259 |
Approved |
0.645 |
Remote Similarity |
NPD4258 |
Approved |
0.6449 |
Remote Similarity |
NPD7475 |
Clinical (unspecified phase) |
0.6444 |
Remote Similarity |
NPD4958 |
Clinical (unspecified phase) |
0.6444 |
Remote Similarity |
NPD4368 |
Phase 2 |
0.6444 |
Remote Similarity |
NPD3692 |
Discontinued |
0.6441 |
Remote Similarity |
NPD3442 |
Approved |
0.6441 |
Remote Similarity |
NPD3441 |
Approved |
0.6438 |
Remote Similarity |
NPD8463 |
Approved |
0.6438 |
Remote Similarity |
NPD6247 |
Clinical (unspecified phase) |
0.6437 |
Remote Similarity |
NPD1393 |
Approved |
0.6436 |
Remote Similarity |
NPD4466 |
Phase 1 |
0.6436 |
Remote Similarity |
NPD3631 |
Phase 3 |
0.6429 |
Remote Similarity |
NPD6104 |
Discontinued |
0.6429 |
Remote Similarity |
NPD4154 |
Approved |
0.6429 |
Remote Similarity |
NPD6593 |
Clinical (unspecified phase) |
0.6425 |
Remote Similarity |
NPD6860 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD2285 |
Clinical (unspecified phase) |
0.6422 |
Remote Similarity |
NPD7238 |
Clinical (unspecified phase) |
0.6418 |
Remote Similarity |
NPD5042 |
Phase 1 |
0.6417 |
Remote Similarity |
NPD6737 |
Phase 2 |
0.6417 |
Remote Similarity |
NPD6738 |
Phase 2 |
0.6415
|
Remote Similarity |
NPD5416 |
Discontinued |